Details
Stereochemistry | RACEMIC |
Molecular Formula | C8H11NO2 |
Molecular Weight | 153.1784 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NCC(O)C1=CC(O)=CC=C1
InChI
InChIKey=LRCXRAABFLIVAI-UHFFFAOYSA-N
InChI=1S/C8H11NO2/c9-5-8(11)6-2-1-3-7(10)4-6/h1-4,8,10-11H,5,9H2
DescriptionSources: http://www.ndrugs.com/?s=norfenefrineCurator's Comment: Description was created based on several sources, including http://www.kegg.jp/entry/D08286 and http://www.ncbi.nlm.nih.gov/pubmed/6351455
Sources: http://www.ndrugs.com/?s=norfenefrine
Curator's Comment: Description was created based on several sources, including http://www.kegg.jp/entry/D08286 and http://www.ncbi.nlm.nih.gov/pubmed/6351455
Norfenefrine or meta-octopamine, also known as 3,β-dihydroxyphenethylamine, is an adrenergic agent used as a sympathomimetic drug which is marketed in Europe, Japan, and Mexico. Along with its structural isomer p-octopamine and the tyramines, norfenefrine is a naturally occurring, endogenous trace amine and plays a role as a minor neurotransmitter in the brain. Norfenefrine controls blood pressure in acute hypotensive states eg pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesth, MI, septicemia, blood transfusion and drug reactions. Adjunct in treatment of cardiac arrest and hypotension.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094251 Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D08286 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Nevadral Retard Approved UseIndications: hypotension |
PubMed
Title | Date | PubMed |
---|---|---|
Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. | 1989 Nov |
|
Heat shock protein 72 and apoptosis indicate cardiac decompensation during early multiple organ failure in sheep. | 2004 Jul |
|
Roles of MMP-2/-9 in cardiac dysfunction during early multiple organ failure in an ovine animal model. | 2005 |
|
[Efficacy and safety of a herbal drug containing hawthorn berries and D-camphor in hypotension and orthostatic circulatory disorders/results of a retrospective epidemiologic cohort study]. | 2005 |
|
Chiral separations on multichannel microfluidic chips. | 2005 Dec |
|
A new copper(I)-tetrahydrosalen-catalyzed asymmetric Henry reaction and its extension to the synthesis of (S)-norphenylephrine. | 2007 |
|
A multichannel electrophoresis microchip platform for rapid chiral selector screening. | 2008 May |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6150569
Curator's Comment: Can also be administered inramuscularly
http://www.ncbi.nlm.nih.gov/pubmed/7197979
For the treatment of female stress incontinence 60 mg were given in slow-release tablets.
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6147146
At 0.1 and 1 umol/l, norfenefrine caused contractions of the rabbit pulmonary artery strips
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QC01CA05
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
||
|
WHO-ATC |
C01CA05
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
||
|
NCI_THESAURUS |
C29709
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
536-21-0
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
CHEMBL358040
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
100000083615
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
m8058
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | Merck Index | ||
|
NORFENEFRINE
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
4538
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
31988
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID3048314
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
D2P3M6SRN5
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
SUB09364MIG
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
C84022
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
DB13378
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
2140
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
1966
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
208-626-8
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY | |||
|
C005310
Created by
admin on Fri Dec 15 16:04:45 GMT 2023 , Edited by admin on Fri Dec 15 16:04:45 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)